Bronchicum Elixir

Bronchicum is a long-standing German herbal medicine brand primarily known for its cough relief products based on thyme and primrose extracts. The brand has its roots in traditional German pharmacy medicine and has been a staple in the DACH region for decades. The manufacturing process is concentrated in Germany to maintain high pharmaceutical standards and quality control for its herbal ingredients.

Historically, Bronchicum was part of the portfolio of various German pharmaceutical firms. For many years, it was managed by Sanofi's consumer healthcare division. However, as of late 2024, it became part of Opella, the standalone consumer healthcare company effectively owned and managed through a strategic partnership involving Sanofi and the private equity firm CD&R. This transition marks a shift toward dedicated consumer healthcare management while retaining its heritage as a trusted German medicinal product.